USPH reports FY2025 Adj. EBITDA $95M (+16%); CFO resigns; dividend raised to $0.46

U S PHYSICAL THERAPY INC /NV

2025-FY EPS reported $1.42 vs consensus $0.68 ▲ beat (+108.8%)

FY2025 net revenue $781M (+16.3% YoY); Adj. EBITDA $95M (+16.2%); GAAP EPS $1.42 vs $1.84 prior.
Q4 net loss per share $(0.44) due to $10.8M redeemable noncontrolling interest charge and $5.2M contingent consideration loss.
CFO Carey Hendrickson resigns effective April 24, 2026; Jason Curtis appointed interim CFO.
Quarterly dividend raised from $0.45 to $0.46 per share; payable April 10, 2026 to record March 13, 2026.
FY2026 Adj. EBITDA guidance $102M-$106M; recent acquisitions add ~$15M annual revenue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.